E-LIB Suche - Ergebnisse für: Mitsudomi, T.

1

P1.11-01 Utility of ctDNA Monitoring during Surveillance in..:

Ohara, S. ; Suda, K. ; Kalashnikova, E....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S204 , 2023

Link: https://doi.org/10.1016/..

2

P1.26-06 Harmonized Maximum Standardized Uptake Value as an..:

Adachi, M. ; Yoshida, Y. ; Yotsukura, M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S280 , 2023

Link: https://doi.org/10.1016/..

3

OA15.06 Differences in Pathologic Assessment by MPR Calcula..:

Kashima, J. ; Inamura, K. ; Hamada, A....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S80-S81 , 2023

Link: https://doi.org/10.1016/..

4

84O Neoadjuvant nivolumab (N) + platinum-doublet chemothera..:

Forde, P.M. ; Spicer, J. ; Girard, N....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S89-S90 , 2023

Link: https://doi.org/10.1016/..

5

OA12.05 Surgical Outcomes with Neoadjuvant Durvalumab + Che..:

Mitsudomi, T. ; Heymach, J.V. ; Reck, M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S71-S72 , 2023

Link: https://doi.org/10.1016/..

6

P1.08-05 On-Target Acquired Resistance to Mobocertinib and ..:

Hamada, A. ; Suda, K. ; Fukuda, S....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S198-S199 , 2023

Link: https://doi.org/10.1016/..

7

OA12.06 Neoadjuvant Durvalumab + Chemotherapy Followed by A..:

He, J. ; Gao, S. ; Reck, M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S72-S73 , 2023

Link: https://doi.org/10.1016/..

8

EP08.01-005 A Multicenter Prospective Observational Study o..:

Hata, A. ; Nishio, M. ; Akamatsu, H....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S337 , 2022

Link: https://doi.org/10.1016/..

9

Consensus for HER2 alterations testing in non-small-cell lu..:

Ren, S. ; Wang, J. ; Ying, J....
ESMO Open. 7 (2022) 1 - p. 100395 , 2022

Link: https://doi.org/10.1016/..

10

EP08.02-085 In vitro Activity and Potential Resistance Muta..:

Suda, K. ; Fujino, T. ; Hamada, A....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S442 , 2022

Link: https://doi.org/10.1016/..

11

EP08.02-146 Proposal of Foretinib as Second-Line TKI after ..:

Fujino, T. ; Suda, K. ; Koga, T....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S472-S473 , 2022

Link: https://doi.org/10.1016/..

12

124P Phase II study of neoadjuvant concurrent chemo-immuno-..:

Miyoshi, T. ; Hamada, A. ; Soh, J....
Immuno-Oncology and Technology. 16 (2022) - p. 100236 , 2022

Link: https://doi.org/10.1016/..

13

Corrigendum to 'Consensus for HER2 Alterations Testing in N..:

Ren, S. ; Wang, J. ; Ying, J....
ESMO Open. 7 (2022) 3 - p. 100482 , 2022

Link: https://doi.org/10.1016/..

14

Final overall survival analysis from the phase III J-ALEX s..:

Hotta, K. ; Hida, T. ; Nokihara, H....
ESMO Open. 7 (2022) 4 - p. 100527 , 2022

Link: https://doi.org/10.1016/..

15

Final overall survival results of WJTOG3405, a randomized p..:

Yoshioka, H. ; Shimokawa, M. ; Seto, T....
Annals of Oncology. 30 (2019) 12 - p. 1978-1984 , 2019

Link: https://doi.org/10.1093/..